DexCom, Inc.
Satış

$DXCM: $375 Price Target Short

164
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion basis. That being said, let me get into a few key points. Dexcom very recently faced a 52 week high, had positive quarterly earnings, is on a bullish run, outperformed other stocks in the same sector, continues stable growth and has a strong buy rating. It does have some long potential as well, given it is a 2800+ employee company. However, given its long bullish run, I think there is a small chance it could be tipping off. That being said, for a quick profit target, I suggest a $375 short and a reinvestment in some higher growth (but maybe higher risk) stocks.

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.